KCM
PFE icon

Kames Capital Management’s Pfizer PFE Stock Holding History

Kames Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$23M Sell
776,625
-242,092
-24% -$6.94M 0.68% 50
2014
Q3 		$28.6M Sell
1,018,717
-58,352
-5% -$1.64M 0.89% 45
2014
Q2 		$30.3M Sell
1,077,069
-39,210
-4% -$1.12M 0.97% 39
2014
Q1 		$34M Sell
1,116,279
-2,555,627
-70% -$76.2M 1.08% 36
2013
Q4 		$107M Sell
3,671,906
-411,291
-10% -$12M 3.55% 4
2013
Q3 		$111M Sell
4,083,197
-139,614
-3% -$3.8M 3.43% 3
2013
Q2 		$112M Buy
+4,222,811
New +$117M 3.95% 2

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Kames Capital Management's PFE Position: Q4 2014 in Review

Kames Capital Management reduced its Pfizer (PFE) stake by 24% in Q4 2014, selling an estimated $6.94M and leaving 776,625 shares worth $23M. The position accounts for 0.68% of the portfolio, ranked #50.

Kames Capital Management first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. The position peaked at $112M in Q2 2013. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Kames Capital Management held 776,625 shares of Pfizer worth $23M as of Q4 2014.
  • Kames Capital Management sold 242,092 Pfizer shares in Q4 2014, an estimated $6.94M.
  • Pfizer made up 0.68% of Kames Capital Management's portfolio in Q4 2014, its #50 holding.
  • Kames Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
  • Kames Capital Management's Pfizer position peaked at $112M in Q2 2013.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Kames Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.